Mankind Pharma Ltd

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 30 July 2026.

The board of Mankind Pharma at its meeting held on 11 July 2026, has inter-alia, considered and approved the: proposal for divestment of 100% stake held in Broadway Hospitality Services (Broadway), a wholly owned subsidiary company; and incorporation of a wholly owned subsidiary company in Netherlands (WOS) to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies.

Mankind Pharma announced that the 35th Annual General Meeting(AGM) of the company will be held on 4 August 2026.

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.11% on the day, quoting at 23888.4. The Sensex is at 75882.34, down 0.17%.Mankind Pharma Ltd has gained around 6.53% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 6.66% in last one month and is currently quoting at 24659.2, up 0.16% on the day. The volume in the stock stood at 3.04 lakh shares today, compared to the daily average of 7.96 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 2429.3, down 0.46% on the day. Mankind Pharma Ltd tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.The PE of the stock is 47.06 based on TTM earnings ending March 26.Powered by Capital Market - Live

Mankind Pharma has allotted 80,872 equity shares under ESOP on 19 May 2026. Consequently, the paid up equity share capital has increased to 41,29,09,200 equity shares having face value of Re 1/- each.

Net profit of Mankind Pharma rose 31.75% to Rs 554.35 crore in the quarter ended March 2026 as against Rs 420.77 crore during the previous quarter ended March 2025. Sales rose 11.81% to Rs 3442.93 crore in the quarter ended March 2026 as against Rs 3079.37 crore during the previous quarter ended March 2025. For the full year,net profit declined 3.92% to Rs 1912.93 crore in the year ended March 2026 as against Rs 1990.96 crore during the previous year ended March 2025. Sales rose 16.96% to Rs 14277.64 crore in the year ended March 2026 as against Rs 12207.44 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3442.933079.37 12 14277.6412207.44 17 OPM %27.0122.19 -25.3424.72 - PBDT905.41746.30 21 3348.613137.55 7 PBT682.33515.43 32 2462.432516.33 -2 NP554.35420.77 32 1912.931990.96 -4 Powered by Capital Market - Live

Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.4% on the day, quoting at 23783.6. The Sensex is at 75701.49, up 0.4%. Mankind Pharma Ltd has gained around 19.34% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 9.71% in last one month and is currently quoting at 24551.05, up 0.39% on the day. The volume in the stock stood at 7.22 lakh shares today, compared to the daily average of 5.15 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2486.3, up 1.66% on the day. Mankind Pharma Ltd is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.The PE of the stock is 57.52 based on TTM earnings ending December 25.Powered by Capital Market - Live

Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2439.2, up 2.69% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Mankind Pharma Ltd has risen around 18.74% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has risen around 9.02% in last one month and is currently quoting at 24135.5, down 0.02% on the day. The volume in the stock stood at 7.39 lakh shares today, compared to the daily average of 4.54 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2435.7, up 2.59% on the day. Mankind Pharma Ltd is up 1.29% in last one year as compared to a 0.65% spurt in NIFTY and a 14.52% spurt in the Nifty Pharma index.The PE of the stock is 55.5 based on TTM earnings ending December 25.Powered by Capital Market - Live

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Mankind Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 2353.3, up 1.46% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. Mankind Pharma Ltd has added around 15.35% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has added around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 3.9 lakh shares today, compared to the daily average of 4.18 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2361.1, up 1.34% on the day. Mankind Pharma Ltd is down 3.25% in last one year as compared to a 1.62% fall in NIFTY and a 12.19% fall in the Nifty Pharma index.The PE of the stock is 54.22 based on TTM earnings ending December 25.Powered by Capital Market - Live